$21.49
-0.01-0.05%
Ult. Agg.: Oct 22, 4:40 AM
$21.02
-0.48-2.23%
Wall Street analyst price targets and consensus rating for NewAmsterdam Pharma Co (NAMS).
Price Target Range — 13 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months